Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allocetra in Primary Knee Osteoarthritis
NCT07580716Phase 2Recruiting
- Sponsor
- Enlivex Therapeutics
- Start
- May 2026
- Primary completion
- Feb 2027
- Modality
- Cell Therapies
- Countries
- 3
01
Overview
A Phase 2 trial of Allocetra in primary knee osteoarthritis, sponsored by Enlivex Therapeutics. Started May 2026; status: recruiting.
02
Drugs
Allocetra
03
Conditions
primary knee osteoarthritis
Beyond the preview
Go deeper on NCT07580716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07580716.